SARS-CoV-2 Lineage C.37; Lambda Variant (Peru/un-CDC-2-4069945/2021) CF (Heat Inactivated) (1 mL)
- Volume: 1.0mL
- Units/Pack: 1
- Storage Condition: -65°C or below
- Hazardous Information: Non-infectious
- Product Type: Inactivated Organism
Description
SARS-Related Coronavirus 2 Lineage C.37; Lambda Variant (Isolate: hCoV-19/Peru/un-CDC-2-4069945/2021) is an enveloped, positive-sense single-stranded RNA virus from the Coronaviridae family and the Betacoronaviridae genus. Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate hCoV-19/Peru/un-CDC-2-4069945/2021 was isolated from a human nasopharyngeal swab in Peru on February 20, 2021.
Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate hCoV-19/Peru/un-CDC-2-4069945/2021 is assigned lineage C.37 (Pango v.3.1.7 2021-07-09), and GISIAD clade GR using Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) tool. The complete genome of the clinical isolate of SARS-CoV-2, hCoV-19/Peru/un-CDC-2-4069945/2021 has been sequenced (GISAID: EPI_ISL_1591097).
Each frozen aliquot contains 1 mL of heat inactivated viral culture fluid. The pre-inactivation titer was determined from an infectious aliquot.
Viral inactivation is verified after heat inactivation by the absence of viral growth in tissue culture-based infectivity assays.